Betulinic acid derivative F6 selectively blocked intestinal FXR yet activated hepatic FXR to reduce harmful ceramides and inflammation, which ameliorated hepatic steatosis, inflammation, and fibrosis (Zhang et al., 2022). Here, NR1H4 is linked to fatty liver disease.